1-2 of 2
Yuehui Wu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Mark Dawson, MD PhD, Eytan M. Stein, MD, Brian J.P Huntly, Anastasios Karadimitris, PhD, Manali Kamdar, Carlos Fernandez de Larrea, Michael J. Dickinson, Paul Sung-Hao Yeh, MBBS, FRCPA, FRACP, Naval Daver, MD, Aristeidis Chaidos, MD PhD, Martin S. Tallman, MD, Raquel Jiménez, MD, Thierry Horner, PhD, January Baron, MS, John Brennan, Geraldine Ferron-Brady, Yuehui Wu, PhD, Natalie Karpinich, Brandon Kremer, Arindam Dhar, MBBS,MDPhD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1377.
https://doi.org/10.1182/blood.V130.Suppl_1.1377.1377
Published: 2017
Journal Articles

Phase I/II Trial of the MEK1/2 Inhibitor Trametinib (GSK1120212) in Relapsed/Refractory Myeloid Malignancies: Evidence of Activity in Patients with RAS Mutation-Positive Disease

Gautam Borthakur, M.D., Leslie Popplewell, MD, Michael Boyiadzis, MD, MHSc, James M. Foran, MD, FRCPC, Uwe Platzbecker, MD, Norbert Vey, Walter B. Roland, MD, PhD, Rebecca L. Olin, MD, MS, Azra Raza, MD, Aristotles Giagounidis, MD, Oliver G. Ottmann, MD, Aref Al-Kali, MD, Elias J. Jabbour, MD, Tapan M. Kadia, M.D., Guillermo Garcia-Manero, MD, John W. Bauman, PhD, Yuehui Wu, PhD, Yuan Liu, Dan Schramek, John Z. Zhu, PhD, Paul Wissel, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 677.
https://doi.org/10.1182/blood.V120.21.677.677
Published: 2012